Gotham Asset Management »

Akebia Therapeutics shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $40k 15k 2.73
2025-06-30 $57k 16k 3.64
2021-06-30 $73k 19k 3.80

More positions owned by Gotham Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tidal Trust I Gotham Enhncd (GSPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Snowflake Com Shs (SNOW)
Amazon (AMZN)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Tidal Trust I Gotham 1000 Valu (GVLU)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Gotham Asset Management

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics